Cancer Research

Helsinn Healthcare SA And Riemser Arzneimittel AG Sign A License Agreement For Aloxi(R) (Palonosetron) And Gelclair(R) In German

LUGANO, Switzerland, February 13 /PRNewswire/-- Helsinn Healthcare SA, a Swiss pharmaceutical group, today announced that it has signed a Distribution and License Agreement for Aloxi(R) (Palonosetron hydrochloride) and Gelclair(R) in Germany with Riemser ...

Article - Anna Ohlden - Feb 13 2008 - 6:31am

Researchers Aim To Prevent Global Prematurity And Stillbirths

SEATTLE, February 18 /PRNewswire/--- Seattle Children's receives US$1 million Gates Foundation grant for research and international summit ...

Article - Anna Ohlden - Feb 18 2008 - 6:30am

ImmunoVaccine Technologies Appoints The Honourable Michael Kirby As Chair

HALIFAX, England, February 20 /PRNewswire/-- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new Board of Directors Chair. Michael Kirby succeeds the late Dr. W ...

Article - Anna Ohlden - Feb 20 2008 - 8:30am

Angiogenesis Discovery May Lead To Blood Vessel Growth Breakthrough

Researchers at Dana-Farber Cancer Institute have found a previously unknown molecular pathway in mice that spurs the growth of new blood vessels when body parts are jeopardized by poor circulation. At present, their observation adds to the understanding of ...

Article - News Staff - Feb 20 2008 - 6:22pm

Rosetta Genomics Announces Conference Call And Webcast Of Fourth Quarter Financial Results

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, February 21 /PRNewswire/-- Rosetta Genomics (Nasdaq: ROSG), today announced it will release fourth quarter financial results on February 29, 2007, before the U.S. markets open. Rosetta Genomics will host a ...

Article - Anna Ohlden - Feb 21 2008 - 9:31am

Genmab And PDL BioPharma Sign Purchase Agreement For Antibody Manufacturing Facility

COPENHAGEN, Denmark and REDWOOD CITY, California, February 21 /PRNewswire/--- Summary: Genmab and PDL BioPharma Have Entered into an Agreement Under Which Genmab Will Acquire PDL's Antibody Manufacturing Facility Located in Brooklyn Park, Minnesota, ...

Article - Anna Ohlden - Feb 21 2008 - 9:31am

FORSTEO(R) Receives Positive Opinion From The European Committee For Medicinal Products For Human Use For The Treatment Of Gluco

INDIANAPOLIS, February 22 /PRNewswire/--- If approved, bone formation agent for osteoporosis would be available for new patient population Eli Lilly and Company (NYSE: LLY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...

Article - Anna Ohlden - Feb 22 2008 - 2:31am

Astellas Receives Positive Opinion From CHMP For Mycamine(R) For The Treatment Of Serious Fungal Infections

STAINES, England, February 22 /PRNewswire/--- New Treatment Option Contributes to Fight Against Healthcare Associated Infections Astellas Pharma Europe Ltd(i) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European M ...

Article - Anna Ohlden - Feb 22 2008 - 7:31am

Writing Won't Cure Cancer- But It Makes Patients Feel Better About It

Expressive writing--writing about one’s deepest thoughts and feelings—may help change the way cancer patients think and feel about their disease. In one of the first studies published in an oncology journal about the benefits of writing therapy, researcher ...

Article - News Staff - Feb 22 2008 - 9:45am

Local Control Of Malignant Melanoma

The case of a 47 year-old woman presenting a wide abdominal zone with vitiligo like hypopigmentation is reported. In 1977 she underwent, in the same site, melanoma (III Clarke's level) extirpation and local immunotherapy by DNCB (dinitrochlorobenzene) ...

Article - Camillo Di Cicco - Mar 6 2010 - 1:14pm